Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  New England Journal of Medicine

• Publication date

  1999-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199906243402502PMID 10379017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.

  1998cited by this paper
• Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Veterans Administration Cooperative Trials SCCOPE Study Group.

  1998cited by this paper
• Equivalence trials.

  1997cited by this paper
• Adverse effects of corticosteroid therapy for COPD. A critical review.

  1997cited by this paper
• Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

  1996cited by this paper
• Trials to assess equivalence: the importance of rigorous methods

  1996cited by this paper
• Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.

  1996cited by this paper
• Corticosteroids and peptic ulcer: meta‐analysis of adverse events during steroid therapy

  1994cited by this paper
• Double-blind trial of steroid tapering in acute asthma.

  1993cited by this paper
• Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis

  1993cited by this paper
• Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis.

  1992cited by this paper
• Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis.

  1991cited by this paper
• Risk of infectious complications in patients taking glucocorticosteroids.

  1989cited by this paper
• A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD.

  1989cited by this paper
• Planning and monitoring of equivalence studies.

  1988cited by this paper
• Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial.

  1987cited by this paper
• Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

  1987cited by this paper
• Analysis of Survival Data.

  1985cited by this paper
• Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.

  1980cited by this paper
• Incidence of serious complications of corticosteroid therapy in respiratory disease. A retrospective survey of patients in the Brompton hospital.

  1968cited by this paper
• STATISTICAL METHODS

  1967cited by this paper

• Prior pulmonary tuberculosis deteriorated all-cause mortality in AECOPD patients after discharge

  2026cites this paper
• IgD‐Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid‐Induced Cell Death

  2026cites this paper
• Efficacy of Nebulized Budesonide and Systemic Corticosteroids During Hospitalization on All-Cause Mortality in AECOPD Patients: A Real-World Study

  2025cites this paper
• The Clinical Use of Dupilumab for Elderly Patients With Severe COPD Exacerbations: A Case Series.

  2025cites this paper
• Corticosteroid use before ICU admission and 90-day all-cause readmission risk in patients with acute exacerbation of chronic obstructive pulmonary disease: an analysis of the MIMIC-IV database

  2025cites this paper
• Stability of blood eosinophils during acute exacerbations in patients with chronic obstructive pulmonary disease

  2025cites this paper
• Digital health technologies for improving the management of people with chronic obstructive pulmonary disease

  2025cites this paper
• Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice

  2025cites this paper
• Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features

  2025cites this paper
• IgD-Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid-Induced Cell Death

  2025cites this paper
• Effect of Added Inhaled Corticosteroids to Systemic Steroids on COPD Exacerbation Outcomes

  2025cites this paper
• Prognostic Value of Dyspnea, Eosinopenia, Consolidation, Acidemia, Fibillation Score in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

  2025cites this paper
• Management of Asthma and COPD Exacerbations in Adults in the ICU

  2024cites this paper
• Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysis.

  2024cites this paper
• Glucocorticoid treatment and new‐onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta‐analysis

  2024influential citation
• Hipertensión arterial pulmonar

  2024cites this paper
• Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD

  2024cites this paper
• Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.

  2024cites this paper
• Corticosteroid Prescribing Patterns in the Emergency Department for Acute Chronic Obstructive Pulmonary Disease Exacerbations: A Retrospective Analysis Following an Educational Intervention

  2024cites this paper
• A Review of Current Evidence for the Use of Steroids in the Medical Intensive Care Unit

  2024cites this paper
• Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations

  2023cites this paper
• Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial

  2023cites this paper
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

  2023cites this paper
• The dual-targeting mechanism of an anti-inflammatory diarylheptanoid from Curcuma zedoaria (Christm.) Roscoe with the capacity for β2-adrenoreceptor agonism and NLRP3 inhibition.

  2023cites this paper
• A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD

  2023cites this paper
• The role of glucocorticoids in increasing cardiovascular risk

  2023cites this paper
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.

  2023cites this paper
• Efficacy and safety of oral corticosteroids to treat outpatients with acute exacerbations of COPD in primary care: a multicentre pragmatic randomised controlled study

  2023cites this paper
• 11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD

  2023cites this paper
• The Evolution and Future of Intensive Care Management in the era of Telecritical care and Artificial Intelligence.

  2023cites this paper
• Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations

  2023cites this paper
• The Management of Acute Exacerbations in COPD: A Retrospective Observational Study and Clinical Audit

  2023cites this paper
• Acute Hypercapnic Respiratory Failure in COPD

  2023cites this paper
• Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD

  2023cites this paper
• Mesoporous Materials as Elements of Modern Drug Delivery Systems for Anti-Inflammatory Agents: A Review of Recent Achievements

  2022cites this paper
• Glucocorticoid therapy in respiratory illness: bench to bedside

  2022cites this paper
• Improving Physiological, Physical, and Psychological Health Outcomes: A Narrative Review in US Veterans with COPD

  2022cites this paper
• Osteosarcopenia in Patients with Chronic Obstructive Pulmonary Diseases: Which Pathophysiologic Implications for Rehabilitation?

  2022cites this paper
• Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index

  2022cites this paper
• Respiratory Viral and Bacterial Exacerbations of COPD—The Role of the Airway Epithelium

  2022cites this paper
• Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease

  2022cites this paper
• Contributions of acquired immunity to the development of COPD in humans and animal models.

  2022cites this paper
• An Updated Review: The Steroid Controversy for the Management of Spinal Cord Injury.

  2021cites this paper
• Personalised Variable vs Fixed Dose Systemic Corticosteroid Therapy in Hospitalized Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective, Multicentered, Randomised, Open-Label Clinical Trial.

  2021cites this paper
• Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma

  2021cites this paper
• The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice.

  2021cites this paper
• Effects of Empirical Glucocorticoid Use on Severe Acute Exacerbation of COPD During Hospitalization

  2021cites this paper
• An Updated Definition and Severity Classification of COPD Exacerbations: The Rome Proposal.

  2021cites this paper
• Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?

  2021cites this paper
• The different phenotypes of COPD.

  2021cites this paper
• Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials

  2021cites this paper
• Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics

  2021cites this paper
• Short-Term Versus Long-Term Systemic Corticosteroid Use in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

  2021cites this paper
• Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

  2021cites this paper
• A multifaceted stewardship intervention helps curb steroid overprescribing in hospitalized patients with acute exacerbations of COPD.

  2021cites this paper
• Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome

  2021cites this paper
• Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations

  2020cites this paper
• COPD_A_269637 2889..2900

  2020cites this paper
• Basic and clinical aspects of glucocorticoid action in bone

  2020cites this paper
• Provider perceptions on steroid dosing in AECOPD: Laying the groundwork for steroid stewardship

  2020cites this paper
• Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study

  2020cites this paper
• COPD_A_236305 567..574

  2020cites this paper
• Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease.

  2020cites this paper
• Impact of the implementation of a pharmacist-driven chronic obstructive pulmonary disease exacerbation orderset in an inpatient setting.

  2020cites this paper
• Factors Associated with Treatment Failure in Patients with Acute Exacerbation of COPD Admitted to the Emergency Department Observation Unit

  2020cites this paper
• Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?

  2020cites this paper
• Corticosteroid Dosing and Glucose Levels in COPD Patients Are Not Associated with Increased Readmissions.

  2020cites this paper
• Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline

  2020cites this paper
• Asthma and COPD

  2020cites this paper
• Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies

  2020cites this paper
• Acute exacerbation of chronic obstructive pulmonary disease Straight to the point of care

  2020cites this paper
• Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease: A systematic review and meta‐analysis

  2020cites this paper
• Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients

  2020cites this paper
• Summary for Clinicians: Clinical Practice Guideline on Pharmacologic Management of Chronic Obstructive Pulmonary Disease.

  2020cites this paper
• How may we improve clinical outcomes for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease? A narrative review about possible therapeutic and preventive strategies

  2020cites this paper
• Use of corticosteroids in asthma and COPD patients with or without COVID-19

  2020cites this paper
• Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation

  2020cites this paper
• The Complex Relationship Between Poor Sleep Quality and Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial

  2020cites this paper
• Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters

  2019cites this paper
• Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids

  2019cites this paper
• Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting

  2019cites this paper
• Sociedade Brasileira de Pneumologia e Tisiologia

  2019cites this paper
• Phosphoinositide 3-kinase ( PI 3 K ) in respiratory disease

  2019cites this paper
• Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee

  2019cites this paper
• Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease ( COPD ) ?

  2019influential citation
• Eosinophil-guided treatment of COPD exacerbations: unfinished business.

  2019cites this paper
• Acute Exacerbation of COPD

  2019cites this paper
• Pulmonary Disorders

  2019cites this paper
• Composite outcomes – the devil is in the details

  2019cites this paper
• Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)

  2019cites this paper
• Chronic obstructive pulmonary disease.

  2019cites this paper
• Right-to-left shunts in lowlanders with COPD traveling to altitude - A randomized controlled trial with dexamethasone.

  2019cites this paper
• Management of Chronic Obstructive Pulmonary Disease

  2019cites this paper
• Procalcitonin and antibiotics in moderate–severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use

  2019cites this paper
• Airway pharmacology: treatment options and algorithms to treat patients with chronic obstructive pulmonary disease.

  2019cites this paper
• Assessment of Work of Breathing in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2019cites this paper
• Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker

  2019cites this paper